BCAL Diagnostics Limited (ASX:BDX)
0.0790
-0.0030 (-3.66%)
May 19, 2025, 11:11 AM AEST
BCAL Diagnostics Market Cap
BCAL Diagnostics has a market cap or net worth of 30.01 million as of May 16, 2025. Its market cap has increased by 13.28% in one year.
Market Cap
30.01M
Enterprise Value
24.30M
Revenue
2.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since July 21, 2021, BCAL Diagnostics's market cap has decreased from 51.72M to 30.01M, a decrease of -41.98%. That is a compound annual growth rate of -13.27%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 16, 2025 | 30.01M | -15.46% |
Dec 31, 2024 | 35.50M | 42.50% |
Dec 29, 2023 | 24.91M | 96.37% |
Dec 29, 2022 | 12.69M | -50.95% |
Dec 29, 2021 | 25.87M | -49.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 115.43B |
Pro Medicus | 28.34B |
Cochlear | 17.45B |
Sonic Healthcare | 12.63B |
Telix Pharmaceuticals | 8.50B |
Ramsay Health Care | 8.23B |
Ansell | 4.68B |
Regis Healthcare | 2.30B |